Chemoinformaics analysis of 12-Methyl-e,e-2,13-octadecadien-1-ol
Molecular Weight | 280.496 | nRot | 14 |
Heavy Atom Molecular Weight | 244.208 | nRig | 2 |
Exact Molecular Weight | 280.277 | nRing | 0 |
Solubility: LogS | -5.185 | nHRing | 0 |
Solubility: LogP | 6.679 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 56.5365 |
nHD | 1 | BPOL | 36.1155 |
QED | 0.304 |
Synth | 3.043 |
Natural Product Likeliness | 1.981 |
NR-PPAR-gamma | 0.024 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.001 |
HIA | 0.041 |
CACO-2 | -4.787 |
MDCK | 0.0000267 |
BBB | 0.052 |
PPB | 1.00136 |
VDSS | 4.287 |
FU | 0.0145211 |
CYP1A2-inh | 0.4 |
CYP1A2-sub | 0.216 |
CYP2c19-inh | 0.312 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.285 |
CYP2c9-sub | 0.97 |
CYP2d6-inh | 0.401 |
CYP2d6-sub | 0.718 |
CYP3a4-inh | 0.622 |
CYP3a4-sub | 0.078 |
CL | 3.292 |
T12 | 0.513 |
hERG | 0.022 |
Ames | 0.003 |
ROA | 0.038 |
SkinSen | 0.956 |
Carcinogencity | 0.026 |
EI | 0.977 |
Respiratory | 0.05 |
NR-Aromatase | 0.178 |
Antiviral | Yes |
Prediction | 0.571334 |